Avricore Health Inc
OTC:AVCRF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (3.6), the stock would be worth $0.06 (23% upside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 2.9 | $0.05 |
0%
|
| 3-Year Average | 3.6 | $0.06 |
+23%
|
| 5-Year Average | 6.4 | $0.1 |
+123%
|
| Industry Average | 2.7 | $0.04 |
-7%
|
| Country Average | 2.9 | $0.05 |
+1%
|
Forward EV/S
Today’s price vs future revenue
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
|
Avricore Health Inc
OTC:AVCRF
|
6.1m USD | 2.9 | -3.7 | |
| JP |
|
Medical Data Vision Co Ltd
TSE:3902
|
37.9T JPY | 9.5 | 227.5 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 5.5 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
26.3B USD | 6.1 | 28.9 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14.4B AUD | 56.5 | 60.8 | |
| JP |
|
M3 Inc
TSE:2413
|
1T JPY | 2.6 | 20.8 | |
| SE |
|
Sectra AB
STO:SECT B
|
50.7B SEK | 21.1 | 94.4 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.9B USD | 5.6 | 42.9 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.6B USD | 6 | 19.1 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 11.4 | -328 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
19.1B CNY | 8.7 | -61.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.7 |
| Median | 2.9 |
| 70th Percentile | 5.7 |
| Max | 15 639 353.3 |
Other Multiples
Avricore Health Inc
Glance View
Avricore Health, Inc. engages in the business of health data and point-of-care technologies. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2001-07-31. The firm is involved in the business of health data and point-of-care technologies (POCT). The firm's flagship offering includes HealthTab. HealthTab is a point-of-care testing solution that combines point-of-care technologies with a cloud-based platform for global health issues. HealthTab offers a screening system, designed to support pharmacist role. The company enables the patients to be active about health by measuring and monitoring safety tests and biomarkers of chronic disease. Rapid Access Safety Test Reporting (RASTR), is a network is the point-of-care based system, which provides direct consumer consent on patient demographics, as well as real-time reporting on data. The firm's subsidiary includes Vanc Marine Pharmaceuticals Inc. and HealthTab Inc.
